The use of drugs in hyperkinetic states: clinical issues

Collaborative governance for creative health: initial programme theories for collaborating across sectors and disciplines.

Perspectives in public health·2026

Dysbiotic Microbiome-Metabolome Axis in Childhood Obesity and Metabolic Syndrome.

Journal of dental research·2025

Local authorities need tailored research ethics processes to support research capacity building.

Public health in practice (Oxford, England)·2025

Social determinants of health inequalities in early phase clinical trials in Northern England.

British journal of cancer·2024

COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2).

NeuroImage. Clinical·2024

Inequalities in dental caries among Indigenous and non-Indigenous children in Australia: A literature review.

Australian dental journal·2024

MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats.

Neuropharmacology·2026

Glycine Transporter 1 Inhibitor, Bitopertin, Changes Excitatory and Inhibitory Network Connectivity in Mouse Medial Prefrontal Cortex.

Neuropharmacology·2026

Alterations of telomere-associated genes and underlying mechanisms in hypoxic-ischemic encephalopathy.

Neuropharmacology·2026

Lumbrokinase ameliorates chronic social defeat stress-induced behavioral impairments through modulation of miR-340-5p and SUMO2 signaling.

Neuropharmacology·2026

Locus Coeruleus mediates the pharmacological effects of 2-Pentadecyl-2-oxazoline in a mouse model of neuropathic pain.

Neuropharmacology·2026

Opto-CRISPR technologies in translational neuropharmacology.

Neuropharmacology·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Immunity, inflammation and disease·2026

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Epilepsia·2026

Related Experiment Videos

The use of drugs in hyperkinetic states: clinical issues

Related Concept Videos

Collaborative governance for creative health: initial programme theories for collaborating across sectors and disciplines.

Dysbiotic Microbiome-Metabolome Axis in Childhood Obesity and Metabolic Syndrome.

Local authorities need tailored research ethics processes to support research capacity building.

Social determinants of health inequalities in early phase clinical trials in Northern England.

COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2).

Inequalities in dental caries among Indigenous and non-Indigenous children in Australia: A literature review.

MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats.

Glycine Transporter 1 Inhibitor, Bitopertin, Changes Excitatory and Inhibitory Network Connectivity in Mouse Medial Prefrontal Cortex.

Alterations of telomere-associated genes and underlying mechanisms in hypoxic-ischemic encephalopathy.

Lumbrokinase ameliorates chronic social defeat stress-induced behavioral impairments through modulation of miR-340-5p and SUMO2 signaling.

Locus Coeruleus mediates the pharmacological effects of 2-Pentadecyl-2-oxazoline in a mouse model of neuropathic pain.

Opto-CRISPR technologies in translational neuropharmacology.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.

Intranasal midazolam vs mouth-dissolving clobazam in terminating seizures: A randomized controlled trial.

Related Experiment Videos

The use of drugs in hyperkinetic states: clinical issues

Related Concept Videos

Related Articles